Skip to content

Clinical study on self-made propolis Jiangzhi formula combined with acupuncture in the treatment of hyperlipidemia

Clinical study on self-made propolis Jiangzhi formula combined with acupuncture in the treatment of hyperlipidemia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005949
Enrollment
Unknown
Registered
2022-04-29
Start date
2022-04-28
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperlipoidemia

Interventions

Acupuncture group:acupuncture
Placebo Group:placebo
Acupuncture and Chinese Medicine Group :Acupuncture and Chinese Medicine

Sponsors

Dongzhimen Hospital, Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ?Meet the diagnostic criteria of hyperlipidemia, and the diagnostic criteria refer to the "Chinese Adult Dyslipidemia Prevention and Treatment Guidelines (2016 Revision)" formulated by the Chinese Adult Dyslipidemia Prevention and Control Guidelines Revision Joint Committee; ?18 years old = age = 65 years old, gender is not limited 3. Those who have not participated in any clinical trials of drugs or medical devices within the past 1 month; 4. Willing and able to comply with the predetermined medical treatment plan, dietary and exercise guidance, laboratory examinations and other research procedures; 5. Voluntarily participate in this study and sign informed consent Book.

Exclusion criteria

Exclusion criteria: ?Patients who have received acupuncture or other lipid-lowering drugs for hyperlipidemia in the past 1 month; ?Patients who are using hormones, thyroxine therapy drugs and other drugs that affect blood lipid metabolism; ?Uncontrolled uncontrolled blood lipid levels that may interfere endocrine or metabolic diseases; ? patients with mental illness, history of drug abuse or alcohol dependence; ? high or very high risk of ASCVD; ? recent 6 months, congestive heart failure, unstable angina pectoris, myocardial infarction, stroke , coronary artery bypass surgery or angioplasty, or a history of unstable or severe peripheral arterial disease; ? pregnant women, lactating women, primary diseases such as cardiovascular, lung, kidney, hematopoietic system and other major diseases such as malignant tumors ? The researcher thinks that it is not suitable to participate in this researcher.

Design outcomes

Primary

MeasureTime frame
Blood lipid test;

Secondary

MeasureTime frame
????????????;Safety index;Determination of curative effect of hyperlipidemia and blood lipids;

Countries

China

Contacts

Public ContactGuihua Tian
rosetgh@163.com+86 13717697488

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026